200 related articles for article (PubMed ID: 25229404)
1. Quality of life and costs in Parkinson's disease: a cross sectional study in Hungary.
Tamás G; Gulácsi L; Bereczki D; Baji P; Takáts A; Brodszky V; Péntek M
PLoS One; 2014; 9(9):e107704. PubMed ID: 25229404
[TBL] [Abstract][Full Text] [Related]
2. [Survey of adults living with epilepsy in Hungary: health-related quality of life and costs].
Péntek M; Bereczki D; Gulácsi L; Mikudina B; Arányi Z; Juhos V; Baji P; Brodszky V
Ideggyogy Sz; 2013 Jul; 66(7-8):251-61. PubMed ID: 23971356
[TBL] [Abstract][Full Text] [Related]
3. [Health related quality of life and disease burden of patients with schizophrenia in Hungary].
Péntek M; Harangozó J; Egerházi A; Kelemen O; Gulácsi L; Baji P; Máttyássy A; Erdélyi R; Lehoczky S; Orlewska E; Vártokné Hevér N; Ferencz A; Brodszky V
Psychiatr Hung; 2012; 27(1):4-17. PubMed ID: 22493145
[TBL] [Abstract][Full Text] [Related]
4. Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
Péntek M; Gulácsi L; Rózsa C; Simó M; Iljicsov A; Komoly S; Brodszky V
Ideggyogy Sz; 2012 Sep; 65(9-10):316-24. PubMed ID: 23126217
[TBL] [Abstract][Full Text] [Related]
5. Costs of dementia in Hungary.
Érsek K; Kovács T; Wimo A; Kárpati K; Brodszky V; Péntek M; Jönsson L; Gustavsson A; McDaid D; Kenigsberg PA; Valtonen H; Gulácsi L
J Nutr Health Aging; 2010 Oct; 14(8):633-9. PubMed ID: 20922339
[TBL] [Abstract][Full Text] [Related]
6. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
7. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
8. [Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary].
Péntek M; Szekanecz Z; Czirják L; Poór G; Rojkovich B; Polgár A; Genti G; Kiss CG; Sándor Z; Májer I; Brodszky V; Gulácsi L
Orv Hetil; 2008 Apr; 149(16):733-41. PubMed ID: 18426720
[TBL] [Abstract][Full Text] [Related]
9. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
Schrag A; Selai C; Jahanshahi M; Quinn NP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
[TBL] [Abstract][Full Text] [Related]
10. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population.
Schrag A; Jahanshahi M; Quinn N
Mov Disord; 2000 Nov; 15(6):1112-8. PubMed ID: 11104193
[TBL] [Abstract][Full Text] [Related]
11. Is EQ-5D a valid quality of life instrument in patients with Parkinson's disease? A study in Singapore.
Luo N; Low S; Lau PN; Au WL; Tan LC
Ann Acad Med Singap; 2009 Jun; 38(6):521-8. PubMed ID: 19565103
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients.
Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; Alvarez-Sánchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martínez-Castrillo JC; Mendoza-Rodríguez A; Moore HP; Rodríguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
Eur J Neurol; 2014 Mar; 21(3):519-24. PubMed ID: 24447695
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in a German cohort of Parkinson's patients assessed with three different measures.
Balzer-Geldsetzer M; Klotsche J; ; Dodel R; Riedel O
J Neurol; 2018 Nov; 265(11):2713-2722. PubMed ID: 30209651
[TBL] [Abstract][Full Text] [Related]
14. Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.
Young MK; Ng SK; Mellick G; Scuffham PA
Qual Life Res; 2013 Jun; 22(5):1065-72. PubMed ID: 22782690
[TBL] [Abstract][Full Text] [Related]
15. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.
Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI
Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study.
Luo N; Ng WY; Lau PN; Au WL; Tan LC
Qual Life Res; 2010 May; 19(4):565-9. PubMed ID: 20204708
[TBL] [Abstract][Full Text] [Related]
17. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
[TBL] [Abstract][Full Text] [Related]
18. [DISEASE BURDEN OP DUCHENNE MUSCULAR DYSTROPHY PATIENTS AND THEIR CAREGIVERS].
Péntek M; Herczegfalvi Á; Molnár MJ; Szőnyi LP; Kosztolányi G; Pfliegler G; Melegh B; Boncz I; Brodszky V; Baji P; Szegedi M; Pogány G; Gulácsi L
Ideggyogy Sz; 2016 Mar; 69(5-6):183-93. PubMed ID: 27468608
[TBL] [Abstract][Full Text] [Related]
19. Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States.
Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
BMC Neurol; 2021 Jan; 21(1):46. PubMed ID: 33516182
[TBL] [Abstract][Full Text] [Related]
20. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
